A total of 71 samples (51 from patients with NSCLC [mutation-positive NSCLC: 17 patients; EGFR mutation-negative in plasma: 34 patients] and 20 surrogate samples) were tested in plasma from both the Roche cfDNA and K2EDTA tubes. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.